Income Statement for Alseres Pharma (ALSE)
| | | Income Statement for Alseres Pharmaceuticals Inc. (ALSE) | | | | | | | Income | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Operating Revenue | - | - | - | - | - | | Adjustments to Revenue | - | - | - | - | - | | Cost of Revenue | 85 | 180 | 213 | 218 | 224 | | Gross Operating Profit | 85 | 180 | 213 | 218 | 224 | | | Selling/General/Admin Expense | (8,406) | (7,897) | (5,520) | (3,981) | (3,532) | | Research & Development | (10,475) | (18,538) | (6,127) | (6,400) | (4,383) | | EBITDA | (18,796) | (26,255) | (11,435) | (10,163) | (7,691) | | Depreciation & Amortization | (85) | (180) | (213) | (218) | (224) | | EBIT | (18,881) | (26,435) | (11,648) | (10,381) | (7,915) | | Interest Income | 209 | - | 195 | 141 | 303 | | Other Income, Net | - | 169 | (2) | - | - | | Total Income Avail For Interest Expense | (18,672) | (26,265) | (11,455) | (10,240) | (7,612) | | Interest Expense | (876) | (90) | (46) | (1,011) | (756) | | Pre-Tax Income | (19,548) | (26,355) | (11,501) | (11,251) | (8,368) | | Income Taxes | - | - | - | - | - | | Minority Interest | - | - | - | - | - | | Net Income from Continuing Operations | (19,548) | (26,355) | (11,501) | (11,251) | (8,368) | | Net Income from Discontinued Operations | - | - | - | - | - | | Net Income from Total Operations | (19,548) | (26,355) | (11,501) | (11,251) | (8,368) | | | Normalized Income | (19,548) | (26,355) | (11,501) | (11,251) | (8,368) | | Extraordinary Income | - | - | - | - | - | | Special Income/Charges | - | - | - | - | - | | Income from Cum. Effect of Acct Change | - | - | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | - | | Other Gains | - | - | - | - | - | | Total Net Income | (19,548) | (26,355) | (11,501) | (11,251) | (8,368) | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | 716 | 480 | 2,731 | | | Basic EPS from Continuing Operations | -1.04 | -1.59 | -1.03 | -1.73 | -1.80 | | Basic EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Basic EPS from Total Operations | -1.04 | -1.59 | -1.03 | -1.73 | -1.80 | | | Diluted EPS from Continuing Operations | -1.04 | -1.59 | -1.03 | -1.73 | -1.80 | | Diluted EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Diluted EPS from Total Operations | -1.04 | -1.59 | -1.03 | -1.73 | -1.80 | | | |
Copyright © QuoteMedia. Data delayed at least 15 min. unless otherwise indicated. RT Realtime, EOD End Of Day, PD Previous Day. Market Data powered by QuoteMedia, financials by Hemscott. Terms of Use. | |
| |
Research Report
Hotstocked.com has a complete research report available for ALSE stock.
Download ALSE report.
Research Report
Get the full report for FREE
| Date: | Sep 5, 2008 |
|---|
| Price: | Free |
|---|
| Pages: | 4 |
|---|
| Document Type: | Adobe Acrobat Reader |
|---|
| | Download ALSE report |
|---|
| | |
|---|
| Example preview: |
|
Attention: Please help us to improve our services by answering the following poll:
Please Leave a comment to tell us how you think we can improve our services.
|
